Your browser doesn't support javascript.
loading
A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet's disease.
Houwen, Tim B van der; Hagen, P Martin van; Kappen, Jasper H; Kuijpers, Robert W A M; Daele, Paul L A van; Dik, Wim A van; Laar, Jan A M van.
Afiliación
  • Houwen TBV; Department of Immunology, Section Clinical Immunology, Erasmus University Medical Center, Rotterdam, Rotterdam, the Netherlands.
  • Hagen PMV; Department of Internal Medicine, Section Clinical Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Kappen JH; Department of Immunology, Section Clinical Immunology, Erasmus University Medical Center, Rotterdam, Rotterdam, the Netherlands.
  • Kuijpers RWAM; Department of Internal Medicine, Section Clinical Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Daele PLAV; Allergy and Clinical Immunology, Immunomodulation and Tolerance Group, National Heart and Lung Institute, Inflammation Repair and Development, Imperial College, London, United Kingdom; Department of Pulmonology, STZ Centre of Excellence for Asthma & COPD, Franciscus group, Rotterdam, United King
  • Dik WAV; Department of Ophthalmology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Laar JAMV; Department of Immunology, Section Clinical Immunology, Erasmus University Medical Center, Rotterdam, Rotterdam, the Netherlands.
Asian Pac J Allergy Immunol ; 40(4): 435-441, 2022 Dec.
Article en En | MEDLINE | ID: mdl-32828115
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Behçet Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Asian Pac J Allergy Immunol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Behçet Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Asian Pac J Allergy Immunol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos